NCT02878109View on ClinicalTrials.gov

DCE-MRI for Assessment of Response to TACE of HCC

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Carcinoma, Hepatocellular
Interventions
DEVICE

Post-treatment phase group

4D-THRIVE and 4D-FLOW using magnetic resonance imaging (MRI)

DEVICE

Pre-treatment phase group

4D-THRIVE and 4D-FLOW using magnetic resonance imaging (MRI)

Trial Locations (1)

H2X 3E4

Centre hospitalier de l'Université de Montréal, Montreal

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Centre de Recherche du Centre Hospitalier de l'Université de Montréal

OTHER

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT02878109 - DCE-MRI for Assessment of Response to TACE of HCC | Biotech Hunter | Biotech Hunter